Reversan
Chemical Name: N-[3-(4-Morpholinyl)propyl]-5,7-diphenylpyrazolo[1,5-a]pyrimidine-3-carboxamide
Purity: ≥95%
Biological Activity
Reversan is a selective inhibitor of multidrug resistance-associated protein 1 (MRP1) and P-glycoprotein (P-gp). Increases the sensitivity of MRP1-overexpressing tumor cells (MCF7/VP) to doxorubicin (Cat. No. 2252), vincristine (Cat. No. 1257) and etoposide (Cat. No. 1226) by 3.8-, 14.6- and 11.6-fold respectively. Increases the efficacy of vincristine and etoposide in murine models of neuroblastoma in vivo. Does not sensitize MRP2, MRP3, MRP4 or MRP5 transporters to known substrates.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma.
Burkhart et al.
Cancer Res., 2009;69:6573
Product Datasheets
Citation for Reversan
The citations listed below are publications that use Tocris products. Selected citations for Reversan include:
1 Citation: Showing 1 - 1
-
Roles of ABCC1 and ABCC4 in Proliferation and Migration of Breast Cancer Cell Lines.
Authors: James E Et al.
Int J Mol Sci 2020;21
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for Reversan
There are currently no reviews for this product. Be the first to review Reversan and earn rewards!
Have you used Reversan?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
